A Glimpse of our Solutions.
Biosimilar Strategy & Opportunity Assessment.
Objectives:
- • Biosimilar Portfolio Expansion for growth
- • Decide the most viable portfolio additions
Approach & solution:
Constraint: Traditional assessments often overemphasize Loss of Exclusivity (LoE) and Reference Product sales estimates and miss out on key strategic factors.
Our approach introduces a multi-dimensional evaluation framework, incorporating:
By integrating these variables, our probabilistic model guides portfolio expansion and investment decisions for any shortlisted product or portfolio.
OUTCOME AND IMPACT
MULTI-VARIATE DECISION MAKING
An exhaustive and objective framework for selecting and investing in high-potential biosimilars.
OPTIMIZED PORTFOLIO MIX
Clear portfolio recommendation along with visibility into risk-return dynamics for each biosimilar.
STRATEGIC ROADMAP
Defined timelines and actionable insights to drive development, manufacturing, and commercial success for the products.
